| Literature DB >> 18374984 |
Isabel María Ponce-Castro1, Carolina González-Rubio, Eva María Delgado-Cerviño, Cynthia Abarrategui-Garrido, Gumersindo Fontán, Pilar Sánchez-Corral, Margarita López-Trascasa.
Abstract
Complement Factor I (CFI) is a regulator of the classical and alternative pathways. CFI has enzymatic activity and is able to cleave C3b and C4b. Homozygous Factor I deficiency is associated with infectious and/or autoimmune diseases. Here we describe the biochemical and genetic characterization in two Spanish families with complete Factor I deficiency. In Family 1, the propositus suffered from several episodes of meningitis for more than a year. Biochemical complement studies showed undetectable Factor I levels in the propositus and in her sister, while their parents and a brother had partial Factor I deficiency and were healthy. In Family 2, three out of five children were homozygous for Factor I deficiency, two of whom suffered from meningitis and the third one from several infections. The parents and the other two siblings were healthy and heterozygous for Factor I deficiency. Molecular studies showed that the two families had different mutations at exon 5 of the Factor I gene, which codifies for module LDLr1. One mutation corresponds to a 772G>A change at the donor splice site that was originally found in a family from Northern England. The second is a new missense mutation 739T>G, that generates a Cys to Gly change.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18374984 DOI: 10.1016/j.molimm.2008.02.008
Source DB: PubMed Journal: Mol Immunol ISSN: 0161-5890 Impact factor: 4.407